Literature DB >> 5774113

Influence of the thyroid state on left ventricular tension-velocity relations in the intact, sedated dog.

R R Taylor, J W Covell, J Ross.   

Abstract

The mechanical properties of left ventricular contraction were described in terms of tension, velocity, length, and time in closed-chest, sedated normal, hypothyroid, and hyperthyroid dogs. Heart rate was controlled at 150 beats/min, and instantaneous contractile element velocity was calculated from left ventricular pressure and its first derivative during isovolumic left ventricular contractions, produced by sudden balloon occlusion of the ascending aorta during diastole. Wall tension was derived from ventricular pressure and volume, the latter being obtained from the pressure-volume relation of the arrested ventricle, and tension-velocity relations were analyzed over a range of ventricular endiastolic volumes. At any level of ventricular volume, the hypothyroid state was associated with a displacement of the tension-velocity relation of the left ventricle downwards and to the left, and the time to peak tension was prolonged (154 msec, normal 139 msec). In the hyperthyroid state, the tension-velocity relation of the left ventricle was displaced upwards and to the right, and the time to peak tension was reduced (80 msec). The changes in the tension-velocity relations indicate that the inotropic state of the left ventricle in the intact dog varies directly with the animal's thyroid state. This influence on myocardial contractility necessarily constitutes an important and integral part of the response of the intact circulation to altered thyroid state.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5774113      PMCID: PMC322282          DOI: 10.1172/JCI106035

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  THE ULTRASTRUCTURAL BASIS OF STARLING'S LAW OF THE HEART. THE ROLE OF THE SARCOMERE IN DETERMINING VENTRICULAR SIZE AND STROKE VOLUME.

Authors:  E H SONNENBLICK; D SPIRO; H M SPOTNITZ
Journal:  Am Heart J       Date:  1964-09       Impact factor: 4.749

2.  CONTRACTILITY OF ISOLATED HEARTS FROM MYXEDEMATOUS RATS.

Authors:  F L MEIJLER
Journal:  Isr Med J       Date:  1963 Nov-Dec

3.  Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man.

Authors:  T E GAFFNEY; E BRAUNWALD; R L KAHLER
Journal:  N Engl J Med       Date:  1961-07-06       Impact factor: 91.245

4.  An analysis of the mechanical components in frog's striated muscle.

Authors:  B R JEWELL; D R WILKIE
Journal:  J Physiol       Date:  1958-10-31       Impact factor: 5.182

5.  Studies of thyroid and sympathetic nervous system interrelationships. I. The blepharoptosis of myxedema.

Authors:  W Y LEE; P K MORIMOTO; D BRONSKY; S S WALDSTEIN
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

6.  The effect of myxedema on the cardiovascular system.

Authors:  L B ELLIS; J G MEBANE; G MARESH; H N HULTGREN; R A BLOOMFIELD
Journal:  Am Heart J       Date:  1952-03       Impact factor: 4.749

7.  Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.

Authors:  W R Wilson; E O Theilen; J H Hege; M R Valenca
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

8.  Time and displacement dependence of cardiac contractility: problems in defining the active state and force-velocity relations.

Authors:  A J Brady
Journal:  Fed Proc       Date:  1965 Nov-Dec

9.  Active stiffness of the intact canine left ventricle. With observations on the effect of acute and chronic myocardial infarction.

Authors:  S A Forwand; K M McIntyre; J G Lipana; H J Levine
Journal:  Circ Res       Date:  1966-11       Impact factor: 17.367

10.  Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects.

Authors:  E O Theilen; W R Wilson
Journal:  J Appl Physiol       Date:  1967-02       Impact factor: 3.531

View more
  22 in total

1.  Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism.

Authors:  H Kobori; A Ichihara; H Suzuki; T Takenaka; Y Miyashita; M Hayashi; T Saruta
Journal:  Am J Physiol       Date:  1997-08

2.  Experimental hyperthyroidism I. Hemodynamics and contractility in situ.

Authors:  B E Strauer; A Scherpe
Journal:  Basic Res Cardiol       Date:  1975 Mar-Apr       Impact factor: 17.165

Review 3.  Contractile proteins in muscle disease.

Authors:  P Cummins
Journal:  J Muscle Res Cell Motil       Date:  1983-02       Impact factor: 2.698

4.  Changes in left ventricular preload and contractility following severe burns in the dog.

Authors:  K Suzuki; T Odagiri; N Takasu; A Maenosono; M Nishina; Y Nakamura; C Fujii; A Kohama
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

Review 5.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

6.  Role of thyroid hormone in postnatal circulatory and metabolic adjustments.

Authors:  J A Breall; A M Rudolph; M A Heymann
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits.

Authors:  J Suko
Journal:  J Physiol       Date:  1973-02       Impact factor: 5.182

8.  Left ventricular function at rest and during exercise in acute hypothyroidism.

Authors:  S Wieshammer; F S Keck; J Waitzinger; J Kohler; W Adam; M Stauch; E F Pfeiffer
Journal:  Br Heart J       Date:  1988-09

9.  Influence of L-thyroxine on cardiac function in athyreotic thyroid cancer patients--an echophonocardiographic study.

Authors:  C Punzengruber; M Weissel
Journal:  Klin Wochenschr       Date:  1988-08-15

10.  Effects of thyroid hormone on calcium handling in cultured chick ventricular cells.

Authors:  D Kim; T W Smith
Journal:  J Physiol       Date:  1985-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.